JGC
BGMS

J. Goldman & Co’s Bio Green Med Solution Inc BGMS Stock Holding History

J. Goldman & Co’s Portfolio BGMS Stock Details BGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-123
Closed -$2.62M – 369
2021
Q2 		$2.62M Buy
123
+24
+24% +$595K 0.1% 204
2021
Q1 		$2.54M Buy
+99
New +$2.79M 0.08% 229

Other funds holding BGMS

TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

J. Goldman & Co's BGMS Position: Q3 2021 in Review

J. Goldman & Co sold out of Bio Green Med Solution Inc (BGMS) in Q3 2021, closing a stake of 123 shares — an estimated $2.62M sold.

J. Goldman & Co first reported a position in BGMS in Q1 2021 and held it in 2 quarters. The position peaked at $2.62M in Q2 2021. 26 funds tracked by Wall St. Rank hold BGMS as of Q3 2021.

  • J. Goldman & Co reported no remaining Bio Green Med Solution Inc position as of Q3 2021 after selling out during the quarter.
  • J. Goldman & Co sold 123 Bio Green Med Solution Inc shares in Q3 2021, an estimated $2.62M.
  • J. Goldman & Co first reported a position in Bio Green Med Solution Inc in Q1 2021 and held it in 2 quarters.
  • J. Goldman & Co's Bio Green Med Solution Inc position peaked at $2.62M in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q3 2021.

Based on J. Goldman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.